Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

After 10 years, the teens treated with weight-loss surgery still had an average 20% reduction in their BMI, researchers report. They also had better markers of heart health, with an average 57% ...

Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight ...

Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss and resolution of common obesity-related comorbidities 10 years later, ...

A new study reveals that among privately insured patients with obesity, weight loss drug use has more than doubled and ...

New research shows adolescents also are less likely to develop type 2 diabetes after gastric bypass and sleeve gastrectomy ...

Researchers have found "tremendous long-term outcomes" for teenagers who underwent surgery to treat their severe obesity a ...

Weight-loss surgery in adolescents with severe obesity can lead to long-term health benefits, such as more frequent remission ...

Employers are rushing to Omada to get the startup's help managing patients on costly drugs like Ozempic.

Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.

Eli Lilly's high profile weight-loss and diabetes drugs fell short of Wall Street sales estimates on Wednesday as supplies ...

Eli Lilly missed Wall Street estimates for its popular weight-loss and diabetes drugs on Wednesday, hit by a decrease in U.S.